Overview
Osama Almalik practices practicing medicine in Riyadh, Saudi Arabia.
His clinical expertise encompasses Angiosarcoma, Breast Cancer, Triple-Negative Breast Cancer, and Mastectomy.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Osama Almalik
Is Osama Almalik a top-rated expert for Angiosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Osama Almalik is classified as an Experienced expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Osama Almalik participate in research or clinical trials?
Yes. Osama Almalik has published 8 articles and abstracts on conditions like Angiosarcoma. You can view a list of Osama Almalik's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AngiosarcomaMr. Almalik isExperienced. Learn about Angiosarcoma.
- Breast CancerMr. Almalik isExperienced. Learn about Breast Cancer.
- MastectomyMr. Almalik isExperienced. Learn about Mastectomy.
- Triple-Negative Breast CancerMr. Almalik isExperienced. Learn about Triple-Negative Breast Cancer.